-
Identification of pancreatic cancer-specific protease substrates for protease-dependent targeted delivery
Slapak, E. J., Zwijnenburg, D. A., Koster, J., Bijlsma, M. F. & Spek, C. A., 1 Dec 2024, In: Oncogenesis. 13, 1, 40.Research output: Contribution to journal › Article* › Academic › peer-review
-
CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer
Slapak, E. J., el Mandili, M., ten Brink, M. S., Kros, A., Bijlsma, M. F. & Spek, C. A., 28 May 2024, In: Cancer Letters. 590, 216845.Research output: Contribution to journal › Article* › Academic › peer-review
-
Protease-responsive mesoporous silica nanoparticles for the targeted treatment of pancreatic cancer
Slapak, E. J., 2024, 209 p.Research output: PhD thesis › Thesis, fully internal
- All publications